OBWG
RXRX icon

Onyx Bridge Wealth Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Onyx Bridge Wealth Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.9K Buy
19,200
+2,000
+12% +$7.73K 0.01% 366
2025
Q4 		$70.3K Sell
17,200
-300
-2% -$1.49K 0.01% 358
2025
Q3 		$85.4K Buy
17,500
+6,000
+52% +$31.5K 0.01% 356
2025
Q2 		$58.2K Buy
+11,500
New +$56.5K 0.01% 309

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Onyx Bridge Wealth Group's RXRX Position: Q1 2026 in Review

Onyx Bridge Wealth Group increased its Recursion Pharmaceuticals (RXRX) stake by 12% in Q1 2026, buying an estimated $7.73K and bringing the position to 19,200 shares worth $58.9K. The position accounts for 0.01% of the portfolio, ranked #366.

Onyx Bridge Wealth Group first reported a position in RXRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $85.4K in Q3 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Onyx Bridge Wealth Group held 19,200 shares of Recursion Pharmaceuticals worth $58.9K as of Q1 2026.
  • Onyx Bridge Wealth Group bought 2,000 Recursion Pharmaceuticals shares in Q1 2026, an estimated $7.73K.
  • Recursion Pharmaceuticals made up 0.01% of Onyx Bridge Wealth Group's portfolio in Q1 2026, its #366 holding.
  • Onyx Bridge Wealth Group first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Onyx Bridge Wealth Group's Recursion Pharmaceuticals position peaked at $85.4K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.